Vaccinex, Inc.
COMBINATION THERAPY WITH SEMAPHORIN-4D BLOCKADE (SEMA4D) AND DC1 THERAPY
Last updated:
Abstract:
Disclosed are compositions and methods comprising the administration of pulsed dendritic cells and an immunoregulator molecule inhibitor for the treatment of cancer.
Status:
Application
Type:
Utility
Filling date:
19 Jun 2020
Issue date:
24 Dec 2020